Tocotrienol |
NCT01450046 |
Completed |
Phase 1 |
Vitamin E δ-Tocotrienol Multiple Dose in Healthy Subjects |
Pancreatic Cancer |
https://ClinicalTrials.gov/show/NCT01450046 |
Tocotrienol |
NCT01446952 |
Completed |
Phase 1 |
Vitamin E δ-Tocotrienol (VEDT) Single Dose in Healthy Subjects |
Pancreatic Cancer |
https://ClinicalTrials.gov/show/NCT01446952 |
Tocotrienol |
NCT02610829 |
Completed |
Not Applicable |
Evaluation of a Short Course of Gamma Tocopherol Supplementation in Adult Subjects |
Gamma Tocopherol Serum Levels |
https://ClinicalTrials.gov/show/NCT02610829 |
Tocotrienol |
NCT02581085 |
Recruiting |
Phase 2 |
Tocotrienol Against the Progression of End Stage Liver Disease |
End Stage Liver Disease|NASH - Nonalcoholic Steatohepatitis|NAFLD - Nonalcoholic Fatty Liver Disease |
https://ClinicalTrials.gov/show/NCT02581085 |
Tocotrienol |
NCT03708354 |
Recruiting |
Phase 1|Phase 2 |
Tocotrienols for Skeletal Muscle Health |
Dynapenia|Postmenopausal Women |
https://ClinicalTrials.gov/show/NCT03708354 |
Tocotrienol |
NCT03705845 |
Recruiting |
Phase 1|Phase 2 |
Tocotrienols for Obesity of Postmenopausal Women |
Obesity|Postmenopausal Women |
https://ClinicalTrials.gov/show/NCT03705845 |
Tocotrienol |
NCT03797222 |
Enrolling by invitation |
Not Applicable |
Vitamin E Supplementation in Hyperinsulinism/Hyperammonemia Syndrome |
Hyperinsulinism-Hyperammonemia Syndrome |
https://ClinicalTrials.gov/show/NCT03797222 |
Tocotrienol |
NCT04140136 |
Recruiting |
Phase 2 |
The Efficacy and Safety of Vitamin E Mixed Tocotrienols In Patients With Amyotrophic Lateral Sclerosis (ALS) |
Amyotrophic Lateral Sclerosis |
https://ClinicalTrials.gov/show/NCT04140136 |
Tocotrienol |
NCT03948737 |
Completed |
Not Applicable |
The Effect of Alpha-tocopherol in Hemolysis and Oxidative Stress Marker on the Red Cell Membrane Beta-thalassemia Major |
Beta Thalassemia Major Anemia|Hemolysis|Oxidative Stress |
https://ClinicalTrials.gov/show/NCT03948737 |
Tocotrienol |
NCT00985777 |
Completed |
Phase 1 |
Vitamin E δ-Tocotrienol Administered to Subjects With Resectable Pancreatic Exocrine Neoplasia |
Pancreatic Neoplasms |
https://ClinicalTrials.gov/show/NCT00985777 |
Tocotrienol |
NCT03807037 |
Recruiting |
Phase 2|Phase 3 |
Safety and Efficacy of Tocotrienols in Post-CABG Atrial Fibrillation |
Atrial Fibrillation |
https://ClinicalTrials.gov/show/NCT03807037 |
Tocotrienol |
NCT01855984 |
Completed |
Phase 2|Phase 3 |
Tocotrienols for School-going Children With ADHD |
Attention Deficit Disorder With Hyperactivity |
https://ClinicalTrials.gov/show/NCT01855984 |
Tocotrienol |
NCT01185769 |
Completed |
Not Applicable |
Study of Tocotrienol Absorption and Distribution Under Different Fat Status |
Absorption |
https://ClinicalTrials.gov/show/NCT01185769 |
Tocotrienol |
NCT01157026 |
Completed |
Not Applicable |
A Pilot Clinical Trial With Tocotrienol on Breast Cancer |
Breast Cancer |
https://ClinicalTrials.gov/show/NCT01157026 |
Tocotrienol |
NCT02058420 |
Completed |
Phase 1|Phase 2 |
Tocotrienols and Bone Health of Postmenopausal Women |
Osteoporosis |
https://ClinicalTrials.gov/show/NCT02058420 |
Tocotrienol |
NCT02560337 |
Completed |
Phase 2 |
Cabazitaxel vs. Tocotrienol in Patients With Recurrent Ovarian Cancer After Failure of Standard Therapy. |
Ovarian Cancer |
https://ClinicalTrials.gov/show/NCT02560337 |
Tocotrienol |
NCT03532763 |
Recruiting |
Not Applicable |
Anti-Inflammatory Effect of Tocotrienol Supplementation in Subjects With Moderately Elevated Inflammation |
Inflammation|Cardiovascular Risk Factor |
https://ClinicalTrials.gov/show/NCT03532763 |
Tocotrienol |
NCT01369043 |
Terminated |
Not Applicable |
The Effects of Vitamin E and Vitamin C and Exercise |
Exercise and Non-exercise Effect Upon Vitamins E and C |
https://ClinicalTrials.gov/show/NCT01369043 |
Tocotrienol |
NCT01749371 |
Completed |
Phase 2|Phase 3 |
Vitamin E Supplementation in Burned Patients |
Burn |
https://ClinicalTrials.gov/show/NCT01749371 |
Tocotrienol |
NCT02263924 |
Unknown status |
Phase 3 |
Stroke and Tocotrienol: Unique Role in Neuroprotection |
Ischemic Stroke |
https://ClinicalTrials.gov/show/NCT02263924 |
Tocotrienol |
NCT00809458 |
Terminated |
Phase 3 |
Biomarker Study of Neoadjuvant Vitamin E in Patients With Locally Treatable Prostate Cancer |
Prostate Cancer |
https://ClinicalTrials.gov/show/NCT00809458 |
Tocotrienol |
NCT04198805 |
Recruiting |
Phase 2 |
Vitamin E and DHA-EE on NAFLD - Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Clinical Trial (PUVENAFLD) |
Non-Alcoholic Fatty Liver Disease|Non-Alcoholic Fatty Liver|Non-Alcoholic Steatohepatitis |
https://ClinicalTrials.gov/show/NCT04198805 |
Tocotrienol |
NCT03765827 |
Completed |
Phase 3 |
Vitamin E on Staple Line and Anastomoses of Roux-en-Y Gastric Bypass |
Postoperative Pain |
https://ClinicalTrials.gov/show/NCT03765827 |
Tocotrienol |
NCT01973400 |
Completed |
Phase 3 |
Neuroprotection by Tocotrienols in Type 1 and Type 2 Diabetes Mellitus |
Diabetic Neuropathy|Cognitive Impairment |
https://ClinicalTrials.gov/show/NCT01973400 |
Tocotrienol |
NCT01743066 |
Completed |
Not Applicable |
Vitamin E Level in Buccal Cells of Arsenicosis Patients |
Chronic Arsenic Poisoning |
https://ClinicalTrials.gov/show/NCT01743066 |
Tocotrienol |
NCT02911688 |
Completed |
Phase 2 |
Effect of Gamma Tocopherol Enriched Supplementation on Response to Inhaled O3 Exposure |
Allergic Asthma |
https://ClinicalTrials.gov/show/NCT02911688 |
Tocotrienol |
NCT01858311 |
Unknown status |
N/A |
Nutrition Blood Outcomes Following Tocotrienol N2B |
Stroke |
https://ClinicalTrials.gov/show/NCT01858311 |
Tocotrienol |
NCT01457690 |
Completed |
Phase 3 |
Study of the Absorption of Vitamin E Water-soluble Form (Pegylated) in the Familial Hypocholesterolemia With Chylomicron Retention |
Hypobetalipoproteinemias |
https://ClinicalTrials.gov/show/NCT01457690 |
Tocotrienol |
NCT02820948 |
Completed |
Phase 3 |
Effect of Vitamin E Ointment on Incisional SSI in Colorectal Surgery |
Surgical Site Infection |
https://ClinicalTrials.gov/show/NCT02820948 |
Tocotrienol |
NCT02104505 |
Completed |
Phase 1|Phase 2 |
Effect of Gamma Tocopherol Enriched Supplementation on Response to Inhaled LPS |
Mild, Allergic Asthma |
https://ClinicalTrials.gov/show/NCT02104505 |
Tocotrienol |
NCT03444298 |
Recruiting |
Phase 2 |
A Study of Gamma Tocopherol-enriched Supplement on Lower Airway Responses to Inhaled Wood Smoke in Healthy Adults |
Airway Inflammation|Asthma |
https://ClinicalTrials.gov/show/NCT03444298 |
Tocotrienol |
NCT00836368 |
Completed |
Phase 1 |
In Vitro Basophil Responsiveness to Allergen Challenge After Gamma-tocopherol Supplementation in Allergic Asthmatics |
Allergic|Asthmatic|Allergy|Asthma |
https://ClinicalTrials.gov/show/NCT00836368 |
Tocotrienol |
NCT04245865 |
Not yet recruiting |
Phase 2 |
Tocotrienol and Bevacizumab in Metastatic Colorectal Cancer |
Colorectal Cancer Metastatic |
https://ClinicalTrials.gov/show/NCT04245865 |
Tocotrienol |
NCT03358524 |
Completed |
Phase 4 |
Effects of Vitamin E Supplementation on Free Radicals and Fat Level of Obese Adolescence in Jakarta, Indonesia |
Obesity, Adolescent|Oxidative Stress |
https://ClinicalTrials.gov/show/NCT03358524 |
Tocotrienol |
NCT01578629 |
Unknown status |
N/A |
NUTRITION: Natural Tocotrienol Against Ischemic Stroke Event |
Ischemic Stroke|Transient Ischemic Attack (TIA) |
N/A |
Tocotrienol |
NCT03582384 |
Not yet recruiting |
Phase 2 |
Use of Tocofersolan (Vedrop®) to Prevent or Treat Refractive Vitamin E Deficiency in Infants and Children |
Short Bowel Syndrome|Vitamin E Deficiency |
https://ClinicalTrials.gov/show/NCT03582384 |
Tocotrienol |
NCT01631838 |
Completed |
Not Applicable |
Effects of Tocotrienols Supplementation on Platelet Aggregation in Subjects With Metabolic Syndrome |
Metabolic Syndrome|Platelet Aggregation, Spontaneous |
https://ClinicalTrials.gov/show/NCT01631838 |
Tocotrienol |
NCT00889434 |
Completed |
Not Applicable |
Efficacy and Safety Study of EGCG/Tocotrienol in 18 Patients With Splicing-mutation-mediated Cystic Fibrosis (CF) |
Cystic Fibrosis |
https://ClinicalTrials.gov/show/NCT00889434 |
Tocotrienol |
NCT02913690 |
Active, not recruiting |
Not Applicable |
Palm Tocotrienols in Chronic Hemodialysis (Malaysia) (PATCH) |
Chronic Kidney Failure |
https://ClinicalTrials.gov/show/NCT02913690 |
Tocotrienol |
NCT02358967 |
Active, not recruiting |
Not Applicable |
Palm Tocotrienols in Chronic Hemodialysis (USA) |
End Stage Renal Disease|Chronic Kidney Disease |
https://ClinicalTrials.gov/show/NCT02358967 |
Tocotrienol |
NCT02776397 |
Unknown status |
Not Applicable |
Relationship of Haptoglobin Phenotype to Vascular Function and Response to Vitamin E Supplementation in Patients With Diabetes Mellitus Type 2: The EVAS Trial |
Diabetes Mellitus |
https://ClinicalTrials.gov/show/NCT02776397 |
Tocotrienol |
NCT02181348 |
Completed |
Phase 1|Phase 2 |
Effect of Vitamin E Supplementation on Hemoglobin Levels in Healthy Adults |
Anemia |
https://ClinicalTrials.gov/show/NCT02181348 |
Tocotrienol |
NCT03855423 |
Recruiting |
Not Applicable |
Maximum Tolerated Dose, Safety and Pharmacologic Study of TRF in Women With Breast Cancer |
Breast Cancer Female |
https://ClinicalTrials.gov/show/NCT03855423 |
Tocotrienol |
NCT01743742 |
Completed |
Phase 4 |
Single High Dose Vitamin C, E in Severe Birth Asphyxia |
Birth Asphyxia |
https://ClinicalTrials.gov/show/NCT01743742 |
Tocotrienol |
NCT03988725 |
Completed |
Not Applicable |
Nonalcoholic Steatohepatitis in HIV Mono-infection: Exploring Non-invasive Methods for Diagnosis and the Therapeutic Role of Vitamin E |
HIV Mono Infection |
https://ClinicalTrials.gov/show/NCT03988725 |
Tocotrienol |
NCT01571921 |
Completed |
Phase 1 |
Gamma-delta Tocotrienol as Potential Maintenance Treatment in Women With Metastatic Breast Cancer |
Healthy Subjects |
https://ClinicalTrials.gov/show/NCT01571921 |
Tocotrienol |
NCT01661530 |
Completed |
Not Applicable |
Piloting a Dietary Vitamin E Intervention During Pregnancy |
Asthma |
https://ClinicalTrials.gov/show/NCT01661530 |
Tocotrienol |
NCT02634606 |
Terminated |
Phase 3 |
Effects of a Supplement Derived From Palm Oil on Cholesterol Levels in the Blood |
Hypercholesterolemia |
https://ClinicalTrials.gov/show/NCT02634606 |
Tocotrienol |
NCT02842567 |
Completed |
Phase 3 |
Hydroxytyrosol and Vitamin E in Pediatric NASH |
NAFLD |
https://ClinicalTrials.gov/show/NCT02842567 |
Tocotrienol |
NCT00386178 |
Completed |
Phase 1 |
Safety Study of a Vitamin E Supplement in Normal Volunteers and Those With Both Allergy and Asthma |
Asthma |
https://ClinicalTrials.gov/show/NCT00386178 |